Cargando…

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates

We present a non-human primate mycobacterial growth inhibition assay (MGIA) using in vitro blood or cell co-culture with the aim of refining and expediting early tuberculosis vaccine testing. We have taken steps to optimise the assay using cryopreserved peripheral blood mononuclear cells, transfer i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanner, Rachel, White, Andrew D., Boot, Charelle, Sombroek, Claudia C., O’Shea, Matthew K., Wright, Daniel, Hoogkamer, Emily, Bitencourt, Julia, Harris, Stephanie A., Sarfas, Charlotte, Wittenberg, Rachel, Satti, Iman, Fletcher, Helen A., Verreck, Frank A. W., Sharpe, Sally A., McShane, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782578/ https://www.ncbi.nlm.nih.gov/pubmed/33397986 http://dx.doi.org/10.1038/s41541-020-00263-7

Ejemplares similares

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
por: Tanner, Rachel, et al.
Publicado: (2021)

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
por: Tanner, Rachel, et al.
Publicado: (2020)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
por: Harris, Stephanie A., et al.
Publicado: (2018)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery()
por: Meyer, Joel, et al.
Publicado: (2013)

A review of clinical models for the evaluation of human TB vaccines
por: O'Shea, Matthew K., et al.
Publicado: (2016)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
por: Satti, Iman, et al.
Publicado: (2022)

Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination
por: Harris, Stephanie A., et al.
Publicado: (2014)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response
por: Matsumiya, Magali, et al.
Publicado: (2014)

Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination
por: Bitencourt, Julia, et al.
Publicado: (2022)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
por: Harris, Stephanie A., et al.
Publicado: (2014)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
por: Pepponi, Ilaria, et al.
Publicado: (2017)

Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults
por: Riste, Michael, et al.
Publicado: (2021)

Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods
por: Rhodes, Sophie J., et al.
Publicado: (2017)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
por: O’Shea, Matthew K., et al.
Publicado: (2018)

Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes
por: Naranbhai, Vivek, et al.
Publicado: (2015)

Towards new TB vaccines
por: Brazier, Benedict, et al.
Publicado: (2020)

Progress and challenges in TB vaccine development
por: Voss, Gerald, et al.
Publicado: (2018)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
por: Tanner, Rachel, et al.
Publicado: (2017)

Author Correction: The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
por: Tanner, Rachel, et al.
Publicado: (2019)

Gene Expression and Cytokine Profile Correlate With Mycobacterial Growth in a Human BCG Challenge Model
por: Matsumiya, Magali, et al.
Publicado: (2015)

Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK
por: Hayward, Sally, et al.
Publicado: (2018)

Aerosol immunisation for TB: matching route of vaccination to route of infection
por: Manjaly Thomas, Zita-Rose, et al.
Publicado: (2015)

TB vaccine development: where are we and why is it so difficult?
por: Wilkie, Morven E M, et al.
Publicado: (2015)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis
por: Zelmer, Andrea, et al.
Publicado: (2016)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
por: Pinpathomrat, Nawamin, et al.
Publicado: (2021)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data()
por: McShane, Helen, et al.
Publicado: (2014)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Disparate Tuberculosis Disease Development in Macaque Species Is Associated With Innate Immunity
por: Dijkman, Karin, et al.
Publicado: (2019)

Quantitative Rapid Test for Detection and Monitoring of Active Pulmonary Tuberculosis in Nonhuman Primates
por: Zhou, Zijie, et al.
Publicado: (2021)

TB vaccine development and the End TB Strategy: importance and current status
por: Fletcher, Helen A., et al.
Publicado: (2016)

TB and SIV Coinfection; a Model for Evaluating Vaccine Strategies against TB Reactivation in Asian Origin Cynomolgus Macaques: A Pilot Study Using BCG Vaccination
por: White, Andrew D., et al.
Publicado: (2021)

The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
por: Fletcher, Helen A., et al.
Publicado: (2009)

A Human Challenge Model for Mycobacterium tuberculosis Using Mycobacterium bovis Bacille Calmette-Guérin
por: Minassian, Angela M., et al.
Publicado: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
por: Pathan, Ansar A., et al.
Publicado: (2012)

Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection
por: Dijkman, Karin, et al.
Publicado: (2021)

Cytomegalovirus infection is a risk factor for tuberculosis disease in infants
por: Müller, Julius, et al.
Publicado: (2019)

Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin
por: McNeill, Eileen, et al.
Publicado: (2018)

The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life
por: Naranbhai, Vivek, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_25b0iubh915st6fsbkvsi05nqm